Share

Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)

Posted on: May 4, 2021

Vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis with thrombocytopenia syndrome (TTS), is a rare, idiosyncratic life-threatening condition that can arise after COVID-19 vaccination with AstraZeneca (AZ) or Johnson & Johnson/Janssen (JJ) vaccines (not reported with Pfizer or Moderna vaccines). This document with supplemental appendices has been developed through extensive consultation with BC medical experts and physician groups to improve awareness and to help guide screening, diagnosis and management of VITT/TTS.

Clickhere Vaccine-Induced Thrombotic Thrombocytopenia (VITT)

More information on treatment and medication guidance can be found on our Treatment and Medication Guidance page